Delving into the Latest Updates on Arcato Laboratories, Inc. with Synapse

概览

疾病领域	数量

神经系统疾病	1

排名前五的药物类型	数量

小分子化药	1

关联

1

项与 Arcato Laboratories, Inc. 相关的药物

ARC-001

靶点-

作用机制-

在研机构

Arcato Laboratories, Inc.

原研机构

Arcato Laboratories, Inc.

在研适应症

术后疼痛

非在研适应症-

最高研发阶段早期临床1期

首次获批国家/地区-

首次获批日期-

1

项与 Arcato Laboratories, Inc. 相关的临床试验

NCT06864884

/ Recruiting早期临床1期

A Phase 1 Randomized, Placebo-Controlled, Blinded Study Evaluating the Safety, Tolerability, and Pharmacokinetics of ARC-001 in Participants Undergoing Third Molar Extraction

The study will test the investigational product gel against placebo (which contains no active ingredient) to determine if it is safe after wisdom tooth extraction. The main questions the study will answer are:
1. How much of the investigational product is absorbed in the blood?
2. Are there side effects?

开始日期2025-02-26

申办/合作机构

Arcato Laboratories, Inc.

100 项与 Arcato Laboratories, Inc. 相关的临床结果

登录后查看更多信息

0 项与 Arcato Laboratories, Inc. 相关的专利（医药）

登录后查看更多信息

100 项与 Arcato Laboratories, Inc. 相关的药物交易

登录后查看更多信息

100 项与 Arcato Laboratories, Inc. 相关的转化医学

登录后查看更多信息